tradingkey.logo

Intuitive Surgical Inc

ISRG

433.990USD

-15.690-3.49%
Close 09/15, 16:00ETQuotes delayed by 15 min
155.54BMarket Cap
59.65P/E TTM

Intuitive Surgical Inc

433.990

-15.690-3.49%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-15

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
24 / 207
Overall Ranking
119 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 34 analysts
Buy
Current Rating
585.732
Target Price
+30.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 34.23% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 75.65.
Undervalued
The company’s latest PE is 59.43, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 320.38M shares, decreasing 1.68% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 33.18M shares of this stock.

Financial Health

Currency: USD Updated2025-09-15

The company's current financial score is 6.37, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 2.25B, representing a year-over-year increase of 19.19%, while its net profit experienced a year-over-year increase of 28.17%.

Score

Industry at a Glance

Previous score
6.37
Change
2.85

Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

8.36

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.75

Company Valuation

Currency: USD Updated2025-09-15

The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 64.52, which is 22.11% below the recent high of 78.78 and -7.33% above the recent low of 69.25.

Score

Industry at a Glance

Previous score
3.75
Change
0.1

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 24/207
No Data

Earnings Forecast

Currency: USD Updated2025-09-15

The company’s current earnings forecast score is 7.82, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Intuitive Surgical Inc is 594.82, with a high of 685.00 and a low of 440.00.

Score

Industry at a Glance

Previous score
7.82
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 34 analysts
Buy
Current Rating
585.732
Target Price
+30.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

94
Total
4
Median
7
Average
Company name
Ratings
Analysts
Intuitive Surgical Inc
ISRG
34
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
Danaher Corp
DHR
26
1
2
3
...
19

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-15

The company’s current price momentum score is 6.97, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 492.99 and the support level at 455.28, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.01
Change
-0.49

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-3.074
Sell
RSI(14)
32.852
Neutral
STOCH(KDJ)(9,3,3)
24.578
Sell
ATR(14)
12.876
High Vlolatility
CCI(14)
-151.435
Sell
Williams %R
97.722
Oversold
TRIX(12,20)
-0.266
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
451.408
Sell
MA10
455.867
Sell
MA20
465.331
Sell
MA50
484.882
Sell
MA100
510.188
Sell
MA200
524.560
Sell

Institutional Confidence

Currency: USD Updated2025-09-15

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 89.37%, representing a quarter-over-quarter decrease of 0.42%. The largest institutional shareholder is The Vanguard, holding a total of 33.18M shares, representing 9.25% of shares outstanding, with 2.95% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
32.51M
+1.41%
BlackRock Institutional Trust Company, N.A.
18.92M
+1.91%
State Street Global Advisors (US)
15.37M
+0.42%
T. Rowe Price Associates, Inc.
Star Investors
13.26M
-5.00%
Fidelity Management & Research Company LLC
9.44M
-10.09%
Geode Capital Management, L.L.C.
8.08M
+4.15%
Capital World Investors
7.52M
+1.24%
Invesco Capital Management (QQQ Trust)
7.41M
+0.10%
JP Morgan Asset Management
5.55M
-23.06%
Norges Bank Investment Management (NBIM)
4.60M
+4.23%
1
2

Risk Assessment

Currency: USD Updated2025-09-15

The company's beta value is 1.62. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.43
Change
-0.09
Beta vs S&P 500 index
1.63
VaR
+3.16%
240-Day Maximum Drawdown
+28.91%
240-Day Volatility
+33.78%
Return
Best Daily Return
60 days
+3.02%
120 days
+14.27%
5 years
+14.27%
Worst Daily Return
60 days
-5.95%
120 days
-8.70%
5 years
-14.34%
Sharpe Ratio
60 days
-2.53
120 days
-0.53
5 years
+0.53
Risk Assessment
Maximum Drawdown
240 days
+28.91%
3 years
+28.91%
5 years
+49.90%
Return-to-Drawdown Ratio
240 days
-0.33
3 years
+0.90
5 years
+0.29
Skewness
240 days
+1.04
3 years
+1.02
5 years
+0.23
Volatility
Realised Volatility
240 days
+33.78%
5 years
+32.31%
Standardised True Range
240 days
+3.23%
5 years
+2.10%
Downside Risk-Adjusted Return
120 days
-71.84%
240 days
-71.84%
Maximum Daily Upside Volatility
60 days
+14.61%
Maximum Daily Downside Volatility
60 days
+23.01%
Liquidity
Average Turnover Rate
60 days
+0.54%
120 days
+0.57%
5 years
--
Turnover Deviation
20 days
+10.81%
60 days
+14.06%
120 days
+19.15%

Peer Comparison

Healthcare Equipment & Supplies
Intuitive Surgical Inc
Intuitive Surgical Inc
ISRG
6.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.98 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
WST
7.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
7.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
7.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
Merit Medical Systems Inc
MMSI
7.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI